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An unprecedented epidemic of chikungunya virus (CHIKV) infection recently started in countries of the Indian Ocean area,
causing an acute and painful syndrome with strong fever, asthenia, skin rash, polyarthritis, and lethal cases of
encephalitis. The basis for chikungunya disease and the tropism of CHIKV remain unknown. Here, we describe the
replication characteristics of recent clinical CHIKV strains. Human epithelial and endothelial cells, primary fibroblasts and,
to a lesser extent, monocyte-derived macrophages, were susceptible to infection and allowed viral production. In contrast,
CHIKV did not replicate in lymphoid and monocytoid cell lines, primary lymphocytes and monocytes, or monocyte-derived
dendritic cells. CHIKV replication was cytopathic and associated with an induction of apoptosis in infected cells.
Chloroquine, bafilomycin-A1, and short hairpin RNAs against dynamin-2 inhibited viral production, indicating that viral
entry occurs through pH-dependent endocytosis. CHIKV was highly sensitive to the antiviral activity of type I and II
interferons. These results provide a general insight into the interaction between CHIKV and its mammalian host.
Citation: Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, et al. (2007) Characterization of reemerging chikungunya virus. PLoS Pathog 3(6): e89. doi:10.
1371/journal.ppat.0030089
Introduction
Chikungunya virus (CHIKV), an alphavirus belonging to the
Togaviridae family, was ﬁrst isolated from a febrile individual
in Tanzania in 1952 [1,2]. CHIKV is transmitted to humans by
several species of mosquitoes, with Aedes aegypti and A.
albopictus being the two main vectors. The symptoms generally
start 4–7 d after the bite. Acute infection lasts 1–10 d and is
characterized by a painful polyarthralgia, high fever, asthenia,
headache, vomiting, rash, and myalgia [2–4]. In Swahili, the
term ‘‘chikungunya’’ means ‘‘the bent walker’’. Indeed, in
numerous patients, a chronic and incapacitating arthralgia
persists for months. During the last 50 years, CHIKV has
caused a number of outbreaks in East and South Africa and in
Southeast Asia [5]. The most recent epidemic reemergences
were documented in Kinshasa (50,000 estimated cases in
1999–2000) [6], Indonesia (2001–2003) [7], the Indian Ocean
islands of Mayotte, Mauritius, Re´union, and the Seychelles
(270,000 cases in 2005–2006 in La Re´union island) [5]), and
India (1.4 to 6.5 million estimated cases in 2006–2007) [8–10].
The magnitude of the recent CHIKV intrusion in La
Re´union island was unexpected, with 40% of the 785,000
inhabitants being infected in 2005–2006. This was the ﬁrst
CHIKV epidemic in a country with an occidental health care
environment. Severe forms of the disease were reported, with
about 250 fatal cases (corresponding to one death per 1,000
infections) [11]. Clinical cases, rarely or never described
before, include lymphopenia, severe dermatological lesions,
lethal hepatitis and encephalitis in adults (often elderly
persons) and newborns, and fetal transmission during
pregnancy leading to neonatal encephalopathy or abortion
[4,12]. Many factors may explain why this virus recently
spread so efﬁciently. CHIKV probably reached La Re´union
for the ﬁrst time, encountering a nonimmune and sensitive
population. The mosquitoes involved in the local trans-
mission (A. albopictus) are abundant and likely present a high
vectorial capacity [13]. The circulating CHIKV strains might
have also acquired particular replication properties. An
extensive genome analysis of recent clinical isolates from
the Indian Ocean outbreak identiﬁed unique molecular
features when compared to the few previously available
sequences from laboratory-adapted viruses [5]. In particular,
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changes in the viral envelope glycoprotein E1 were observed,
potentially affecting viral fusion, assembly, and/or tropism.
There is a critical lack of knowledge on the biology of
CHIKV, contrasting with related model alphaviruses like
Sindbis virus (SINV), Semliki Forest virus (SFV), and Ross
River virus (RRV); this probably reﬂects the fact that CHIKV
has mostly afﬂicted persons in developing countries. Alphavi-
ruses are enveloped, single-stranded, positive polarity RNA
viruses [2]. Alphaviruses attach to poorly characterized
receptors on many different cell types in various species. The
E1 spikeproteindrives the fusionprocess, andE2 interactswith
cellular receptors [14,15]. Individual viruses have different, but
wide tropism, accounting somewhat for different disease
patterns [2]. Viral entry generally occurs through receptor-
mediated endocytosis, and fusion is dependent of endosomal
acidiﬁcation [16–19]. In the 1960s, CHIKV was used to
stimulate type I interferon (IFN) production from chick
embryo–like ﬁbroblasts [20,21], and IFN most likely plays a
prominent role in viral clearance and disease pathogenesis.
Prior studies from the 1960s to 1980s have demonstrated that
CHIKV replicates in various nonhuman cell lines, including
Vero cells, chick embryo ﬁbroblast–like cells, BHK21, L929,
and Hep-2 cells [22–25], inducing generally a signiﬁcant
cytopathic effect (CPE) [2]. To our knowledge, the interaction
of CHIKV with human primary cells has not been extensively
characterized. Here, we report on the replication character-
istics and the tropism of clinical CHIKV strains from La
Re´union island and provide a general insight into the
interaction between CHIKV and its human host.
Results
Analysis of CHIKV Replication
Virtually nothing is known about the interactions of
CHIKV with human cells. We thus designed various assays
to study CHIKV replication in cell cultures. Four clinical
strains (isolated from patients from La Re´union), for which
the genome has been sequenced [5], were analyzed. CHIKV-21
and CHIKV-27 strains were isolated, respectively, from the
serum and cerebrospinal ﬂuid of two newborns suffering
from encephalopathy, whereas CHIKV-49 and CHIKV-115
came from two young adults with a classical form of the
disease [5]. The four strains were genetically close, with only
one polymorphic residue (at codon 226) in the E1 glyco-
protein [5]. These Re´union isolates showed 1%–2% amino
acid changes in their nonstructural and structural proteins
when compared to the reference strain (isolated in 1952 in
Tanzania). To avoid selection of minor laboratory-adapted
variants [26], viruses were ampliﬁed only twice, in C6/36
mosquito cells, before characterization. Viral titers of C6/36
supernatants were measured using a standard procedure
(infection of Vero cells with serial dilutions of supernatants
to be tested, and measure of the appearance of a CPE) [27]
and were conﬁrmed with a focus immunoassay (see Materials
and Methods). Titers reached 106–107 tissue culture infec-
tious dose 50 (TCID50)/ml in C6/36 supernatants for the four
strains.
We ﬁrst used the HeLa epithelial cell line as target. HeLa
cells were exposed to CHIKV-115 at a high multiplicity of
infection (moi), and the presence of viral proteins was
examined by immunoﬂuorescence, after staining with a
monoclonal antibody directed against a conserved epitope
of alphavirus capsid (C) [28]. At 2 h post-infection (pi), a weak
punctuate staining was observed, likely corresponding to
incoming virions bound or internalized by target cells (not
shown). At 24 h pi, the anti-C staining was more intense
throughout the cytosol (Figure 1A). Mouse polyclonal anti-
CHIKV antibodies also gave a strong signal in infected cells,
staining both the cytosol and plasma membrane (Figure 1A).
Quantiﬁcation of the fraction of infected cells was then
performed by ﬂow cytometry. At a high viral dose (moi 10),
80%–100% of the cells were positive for CHIKV antigens at
24–48 h pi (Figure 1B and 1C). Productive infection and
expression of viral proteins increased according to the initial
inoculum (Figure 1B). A kinetic analysis showed that infection
spread rapidly in cultures, thus indicating that HeLa cells
were capable of producing infectious virus (Figure 1C). At
high mois (10 and 1), about 50% of the cells were infected as
soon as 8–16 h pi, whereas there was a delay in the
appearance of CHIKV-positive cells at a lower moi (0.1)
(Figure 1C). This rapid viral propagation was associated with
release of high levels infectious virus in supernatants, reach-
ing 106–107 TCID50/ml at 24–48 h pi for the high mois (10
and 1) and at 48–72 h pi for the low moi (0.1) (Figure 1D).
Similar results were obtained with the four CHIKV strains,
indicating that they behave similarly in HeLa cells (Figure 1E).
Alphaviruses are known to produce a marked CPE in
vertebrate cell cultures [2]. This was also the case for CHIKV
in HeLa cells, in which extensive cell death occurred at 24 h
pi (at the high moi), as observed by immunoﬂuorescence and
measured in a colorimetric assay (MTT cell viability test)
(Figure 2A and 2B). Again, this CPE varied depending on the
viral inoculum (Figure 2B). Dying cells were positive for
CHIKV antigens, and a large amount of cell debris was visible
(Figure 2A). Death of infected cells was associated with
apoptosis, as assessed by the presence of numerous active
caspase-3 and CHIKV double-positive cells (Figure 2C). In
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Author Summary
Chikungunya virus (CHIKV) is a reemerging alphavirus responsible
for an unprecedented epidemic in countries of the Indian Ocean
region, causing an acute and painful syndrome with strong fever,
asthenia, skin rash, polyarthritis, and lethal cases of encephalitis. The
most recent epidemic reemergences were documented in Kinshasa,
(50,000 estimated cases in 1999–2000), in Indonesia (2001–2003),
the Indian Ocean islands of Mayotte, Mauritius, Re´union, and the
Seychelles (270,000 cases in 2005–2006 in La Re´union island), and in
India (1.4 to 6.5 million estimated cases in 2006–2007). There is a
critical lack of knowledge on the biology of CHIKV. In particular,
virtually nothing is known about the interaction of CHIKV (and of
most alpahaviruses) with human primary cells. We have studied the
replication characteristics and the tropism of clinical CHIKV strains
from La Re´union. We designed various assays and reagents to follow
viral replication, and we report here that adherent cells (epithelial
and endothelial cells, primary fibroblasts), as well as macrophages,
are sensitive to infection. In contrast, blood cells did not allow viral
replication. We also characterized viral entry pathways and
sensitivity to interferons. These results provide a general insight
into the interaction between CHIKV and its mammalian host. This
paper is the result of a collaborative effort between numerous teams
from Institut Pasteur, the Groupe Hospitalier Sud Re´union, and other
institutions. Our aim was to establish a task force with multiple and
complementary expertise on virology, immunology, and cell biology
in order to characterize this enigmatic virus.
three independent experiments, 75% 65% of CHIKV-
positive cells also expressed an active caspase-3, at day 1 pi.
Infected cells were also positive for another marker of
apoptosis (TUNEL staining, not shown).
Of note, we repeatedly observed an apparent discrepancy
between the number of productively infected cells analyzed
by ﬂow cytometry, and virus titers in supernatants (compare,
for example, Figure 1C and 1D when a low moi is used). This
is likely the consequence of a rapid and extensive mortality of
infected cell populations, especially at high mois: the
percentage of infected cells is actually measured on living
cells. It is also possible that the ﬂow cytometry assay mostly
detects cells expressing high levels of viral proteins.
We also characterized CHIKV by Western blot analysis.
Various viral proteins were detected in lysates of CHIKV-
infected HeLa cells and in viral particles pelleted from the
supernatants (Figure 3A). From their apparent molecular
weight, major viral proteins in cell lysates were likely the p62
precursor of the envelope glycoprotein E2 (62 kDa), the
envelope glycoprotein E1 (52 kDa), and the capsid C (36 kDa)
[25]. Other bands in cell lysates probably corresponded to
nonstructural and structural proteins, as well as precursors or
intermediate cleavage products [2,25,29]. The three main
bands in pelleted supernatants likely corresponded to low
levels of p62, the E2–E1 doublet (56 and 52 kDa) and C
(Figure 3A). A similar Western blot proﬁle was obtained with
Figure 1. CHIKV Infection of HeLa Cells
(A) HeLa cells were exposed to CHIKV-115. At 24 h pi, cells were fixed and stained with an anti-alphavirus capsid mAb or with polyclonal anti-CHIKV
antibodies, and analyzed by confocal microscopy.
(B) Quantification of CHIKV-infected cells by flow cytometry. HeLa cells were exposed to CHIKV-115 at the indicated moi. At 24 h pi, cells were fixed,
permeabilized, stained with anti-CHIKV antibodies, and analyzed by flow cytometry. Similar results were obtained with the anti-capsid mAb.
(C) Kinetic analysis. HeLa cells were infected as described in (B) and analyzed at the indicated time points. Data are a compilation (with standard
deviation [SD]) of three independent experiments.
(D) Viral release in supernatants. Levels of infectious virions in supernatants were measured by limiting dilution on Vero cells and are expressed as
TCID50/ml. Data are a compilation (with SD) of three independent experiments.
(E) Comparison of the infectivity of four CHIKV strains. Mean 6SD of five independent experiments are depicted, with 100% corresponding to values
obtained with CHIKV-115, at days 1 and 2 pi, with mois of 10 and 1.
NI, noninfected cells.
doi:10.1371/journal.ppat.0030089.g001
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sera from patients (not shown), indicating that these viral
proteins are synthesized and immunogenic in infected
individuals.
An electron microscope study revealed the presence of
numerous viral-like particles in CHIKV-infected cells (at 36 h
pi) (Figure 3B). Virions displayed the characteristic features
of alphaviruses [30,31]: a size of 50–70 nm, an icosahedral-like
shell of C proteins, and the presence of viral envelope
glycoproteins on their surface (Figure 3B). Although the
intracellular site of alphavirus budding has been debated
[30,31], our analysis indicates that CHIKV appears to bud
mostly at the plasma membrane of HeLa cells.
Figure 2. CHIKV Is a Cytopathic Virus
(A) CHIKV-infected dying cells. At 24 h after CHIKV infection, HeLa cells were fixed, stained with anti-CHIKV antibodies, and analyzed by confocal
microscopy.
(B) Viability of cell cultures. HeLa cells were infected with CHIKV at the indicated moi. After 24 h pi, cell viability was measured in a colorimetric assay
(MTT cell viability test). Data are mean 6SD of triplicates and representative of five independent experiments;
(C) Apoptosis of CHIKV-infected cells. At 24 h pi (moi 10), HeLa cells were doubly stained with anti-active caspase-3 and anti-capsid antibodies and
analyzed by flow cytometry. The percentage of caspase-3 positive and negative cells among CHIKV positive cells is depicted. Similar results were
obtained with another marker of apoptosis (TUNEL, not shown). Data are representative of three independent experiments.
NI, noninfected cells.
doi:10.1371/journal.ppat.0030089.g002
PLoS Pathogens | www.plospathogens.org June 2007 | Volume 3 | Issue 6 | e890807
Characterization of Chikungunya Virus
Altogether, these results demonstrate that CHIKV efﬁ-
ciently propagates in HeLa cells, causing a rapid death of
infected cells by apoptosis. Viral replication can be evaluated
with various methods, including detection of infected cells by
immunoﬂuorescence or ﬂow cytometry, measurement of viral
release in supernatants, and quantiﬁcation of cell viability.
Cell Tropism of CHIKV
We tested a panel of immortalized and primary human
cells for their ability to replicate CHIKV. The epithelial-
derived cell lines HeLa, 293T, and BEAS-2B, as well as
primary ﬁbroblasts (Hs 789.Sk skin cells and MRC5 lung cells),
were highly susceptible to the virus. After 24 h of infection,
more than 60% of the cells were CHIKV-positive by ﬂow
cytometry (Figure 4A and 4B) and by immunoﬂuorescence
analysis (not shown). CHIKV infection was associated with
extensive cell mortality and with the release of high levels of
infectious virus in supernatants (not shown). Interestingly,
resting MRC5 cells, obtained by maintaining conﬂuent
cultures in serum-free medium for at least 10 d before viral
exposure (95% of the cells at G0/G1 by ﬂow cytometry
analysis of the cell cycle, not shown), were also susceptible to
infection (Figure 4B). Therefore, CHIKV replicates in
dividing and nondividing cells. We also identiﬁed an
epithelial cell line (A549 alveolar cells), which was resistant
to CHIKV infection. Less than 5% of the cells express CHIKV
antigens at day 2 pi, without any CPE (Figure 4A and 4B). We
then tested two human endothelial cell lines, TrHBMEC and
hCMEC/D3, isolated from the bone marrow and the brain,
respectively [32,33]. Interestingly, TrHBMEC cells were read-
ily infected and killed by CHIKV, whereas hCMEC/D3 cells
Figure 3. Assembly and Release of CHIKV
(A) Western blot analysis of CHIKV proteins. HeLa cells were exposed to the indicated CHIKV strains (moi 10). Cell lysates and pelleted supernatants were
analyzed by Western blot 24 h pi, with a mix of anti-capsid mAb and anti-CHIKV antibodies. The predicted viral proteins are indicated on the right.
(B) Gallery of electron micrographs of CHIKV-infected HeLa cells. Cells were analyzed at 36 h pi. CHIKV mostly buds at the plasma membrane of HeLa
cells. Viral particles were not detected in noninfected cells (not shown). Bars represent 1 lm in the upper panels and 100 nm in the lower panels.
NI, noninfected cells.
doi:10.1371/journal.ppat.0030089.g003
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Figure 4. Cell Tropism of CHIKV
(A–C) The indicated human cell lines or primary cells were exposed to CHIKV at an moi of 10. At 24 h pi, cells were fixed, stained with anti-CHIKV
antibodies, and analyzed by flow cytometry. The percentage of CHIKV-infected cells is indicated. Data are representative of at least three independent
experiments. For primary cells, at least three different donors were analyzed.
(A) Examples of sensitive and refractory cell types.
(B) Sensitivity of adherent cells to CHIKV infection.
(C) Sensitivity of primary blood-derived cells to CHIKV infection. The indicated cell lines, as well as nonactivated PBMCs, activated CD4þ lymphocytes,
monocytes, and monocyte-derived DCs were analyzed.
doi:10.1371/journal.ppat.0030089.g004
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were much more resistant (Figure 4B). With hCMEC/D3, only
1% of the cells were CHIKVþ at 24 h pi, this fraction did not
increase over time, and no obvious CPE was observed (not
shown). Of note, monkey Vero cells were also sensitive to
CHIKV infection (Figure 4B).
The acute phase of chikungunya disease is associated with a
high peak of viremia, which can reach 108 viral RNA copies/
ml (P. Laurent, K. Le Roux, P. Grivard, G. Bertil, F. Naze, et al.,
unpublished data). We thus asked whether blood-derived cell
lines support CHIKV replication. Jurkat (CD4þ T lymphoid
cells), THP-1 and U937 (monocytoid cells), and B-420 (EBV-
transformed B cells) were refractory to CHIKV infection
(Figure 4B). We then examined the sensitivity of primary
blood cells. We tested nonactivated and PHA-activated
peripheral blood mononuclear cells (PBMCs), as well as
puriﬁed cell subsets, including CD14þ monocytes, activated
CD4þ T cells, immature and mature monocyte-derived
dendritic cells (DCs). None of these cell types were sensitive
to CHIKV infection, and viral exposure did not induce any
apparent toxicity in these cells (Figure 4C).
We documented further the tropism of CHIKV by design-
ing an assay to characterize viral binding to these various
sensitive and restrictive cells. Target cells were incubated at
48 C for 1 h with CHIKV (at mois of 10 and 50), and the
amount of bound viral materials was measured by ﬂow
cytometry after staining with anti-CHIKV antibodies. Viral
binding varied depending on the cell type. An example of two
cell types with strong binding (Vero and BEAS-2B cells) and
two others with undetectable binding (THP-1 and primary
monocytes) is provided in Figure 5, while Table 1 summarizes
results obtained with the whole panel of tested cells.
Interestingly, there was generally a good correlation between
the efﬁciency of viral binding and sensitivity to infection
(Table 1).
In conclusion, these results indicate that CHIKV readily
infects most (but not all) of the adherent cell lines or primary
cells tested, whereas blood cells are refractory to the virus.
The absence of infection is generally due to a poor binding of
Figure 5. Binding of CHIKV to Target Cells
The indicated human cell lines or primary cells were exposed to CHIKV at the indicated moi for 1 h at 4 8C. Cells were fixed, stained with anti-CHIKV
antibodies, and analyzed by flow cytometry. Data are representative of three independent experiments. NI, noninfected cells.
doi:10.1371/journal.ppat.0030089.g005
Table 1. Analysis of CHIKV Binding and Sensitivity to Infection of
a Panel of Adherent and Nonadherent Cells
Name Cell Type Binding Infectivity
HeLa Cervical carcinoma epithelial cell line þ þ
293T Kidney epithelial cell line þ þ
Hs 789.Sk Primary skin fibroblasts nd þ
ThBMEC Bone marrow endothelial cell line þ þ
hCMEC/D3 Brain endothelial cell line  
MRC5 Primary lung fibroblasts þ þþ
BEAS-2B Bronchial epithelial cell line þþ þþ
A549 Alveolar epithelial cell line þ 
Vero Monkey kidney epithelial cell line þþ þþ
Jurkat CD4þ T lymphoid cell line  
THP-1 Monocytoid cell line  
U937 Monocytoid cell line  
B-420 EBV-transformed B cell line  
PBMC Primary peripheral blood
mononuclear cells
 
CD4þ T cells Primary CD4þ T lymphocytes  
Monocytes Primary CD14þ monocytes  
Dendritic cells Primary monocyte–derived cells  
Macrophages Primary monocyte–derived cells þ þ
Cells were analyzed as depicted in Figures 4 and 5. Results are representative of at least
three independent experiments. Analysis of binding: þþ and þ correspond, respectively,
to at least a 3-fold and 2-fold increase in the background signal (obtained in noninfected
cells). Analysis of infection:þþ andþ correspond, respectively, to .80% and 5%–50% of
infected cells at day 1 pi with an moi of 10. denotes that less than 3% of the cells were
positive for CHIKV at days 1, 3, and 5.
doi:10.1371/journal.ppat.0030089.t001
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incoming CHIKV to target cells. Of note, similar results were
obtained with the four CHIKV strains analyzed and with
viruses produced in either mosquito (C6/36) or mammalian
(HeLa) cells, indicating that there are no obvious differences
in the tropism of these isolates in cell culture.
CHIKV Productively Infects Human Primary Macrophages
Since monocytes are insensitive to CHIKV, we asked
whether macrophages allow CHIKV replication. Monocyte-
derived macrophages were prepared from PBMCs of healthy
donors [34]. Cells expressed CD14, CD4, and CCR5 (markers
of the macrophage lineage), strongly adhered to bottom wells,
and displayed high phagocytic activity (not shown). Macro-
phages were exposed to CHIKV for 2–4 h at 37 8C, the
unbound virus was removed by extensive washing, and viral
replication was assessed over time by immunoﬂuorescence
analysis and by measuring the release of infectious virus
(Figure 6). At 4 h pi, some faint intracellular dots were visible,
likely corresponding to incoming virions. At a later time, (24
h pi), productively infected cells, with a strong CHIKV signal,
were detected in the cultures. Depending on the donors,
approximately 5%–50% of the cells were positive, with either
the anti-C monoclonal antibody (mAb) (not shown) or
polyclonal anti-CHIKV antibodies, at 24–48 h pi (Figure
Figure 6. CHIKV Productively Infects Human Primary Macrophages
(A–C) Human monocyte–derived macrophages were exposed to CHIKV for 4 h and extensively washed, and CHIKV replication was analyzed by different
methods. Data are representative of at least four independent experiments, with cells from eight different donors.
(A) CHIKV-infected macrophages. Cells were infected with CHIKV at an moi of 10. At the indicated time points, cells were stained with anti-CHIKV
antibodies and analyzed by confocal microscopy. Two magnifications are depicted (objectives325 and340). NI, noninfected cells.
(B) Release of infectious virus in supernatants. Macrophages were infected at various mois as stated. At the indicated time points, levels of infectious
virions in supernatants were measured by limiting dilution on Vero cells. Results are expressed as TCID50/ml. Macrophages from three representative
donors are depicted.
(C) Viral RNA in supernatants. Levels of viral RNA in supernatants from the same experiment depicted in (B) were measured by real-time PCR.
doi:10.1371/journal.ppat.0030089.g006
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6A). Infectious viral material was released in the super-
natants, reaching 104–105 TCID50/ml at 24–48 h, and then
slowly declining over time (Figure 6B). Similar results were
obtained with cells from eight different donors and with
various CHIKV strains (not shown). We also quantiﬁed viral
RNA release over time with a real-time PCR assay (P. Laurent,
K. Le Roux, P. Grivard, G. Bertil, F. Naze, et al., unpublished
data). A level of 106–107 viral RNA copies was reached at 72 h
pi in macrophages from three different donors. Results with
cells from two donors, infected at mois of 10 and 50, and from
one donor infected at mois of 1 and 10, are depicted Figure
6C. Interestingly, the amount of infectious virions peaked at
day 1 or 2 and then decreased, whereas the production of
viral RNA did not decline so rapidly. This suggests that
infected, dying macrophages may release noninfectious viral
RNA. Altogether, these results indicate that CHIKV produc-
tively infects monocyte-derived macrophages. The extent of
viral replication in macrophages is, however, lower than in
HeLa cells.
CHIKV Entry Pathways
Alphaviruses like SINV and SFV penetrate target cells
through clathrin-mediated endocytosis, the low pH of the
endosomal compartment promoting conformational changes
of envelope glycoprotein and viral fusion [15,16,18]. We
examined whether CHIKV infection requires a low endo-
somal pH for entry. HeLa cells were treated with two
compounds that impair intracellular vesicle acidiﬁcation,
baﬁlomycin-A1, an inhibitor of vacuolar proton-ATPases
[35], or the weak base chloroquine. Both compounds potently
inhibited the appearance of CHIKV-positive cells and
CHIKV-associated CPE (Figure 7A and 7B). Baﬁlomycin-A1
was efﬁcient at doses from 2.5 to 250 nM, without obvious
cytotoxicity, whereas the active concentration range of
chloroquine was much narrower: this compound fully
inhibited CHIKV infection at 10 lM, but was toxic at 100
lM (Figure 7B). Of note, no inhibitory effect was observed if
addition of these two compounds was delayed until 3 h after
CHIKV exposure (Figure 7A). This suggests that the require-
ment for an acidic compartment is a feature of an early step
of the viral cycle.
We studied further the role of the clathrin endocytic
pathway by knocking down the expression of dynamin-2
(Dyn-2), a key protein required for the formation of clathrin-
coated pits and vesicles, and of caveolae [18,36,37]. This was
achieved by using lentiviral vectors expressing EGFP and a
short hairpin RNA (shRNA) against Dyn-2 [38]. Transduction
of HeLa cells inhibited Dyn-2 expression in EGFPþ cells
(Figure 7C), with the expected functional implications, as
evidenced by a signiﬁcant increase in transferrin receptor
surface expression (Figure 7C). Interestingly, HeLa cells
lacking Dyn-2 were largely refractory to CHIKV-infection,
whereas cells transduced with a vector coding for a control
shRNA were normally infected (Figure 7D). In four inde-
pendent experiments, the absence of Dyn-2 was associated
with a 20-fold reduction in the sensitivity of HeLa cells to
CHIKV (Figure 7D). Altogether, these experiments strongly
suggest that CHIKV requires an active clathrin-dependent
pathway of internalization and targeting of a low pH
endosomal compartment for successful infection.
CHIKV Replication Is Sensitive to IFNs
IFN was ﬁrst discovered in 1957 as an undeﬁned substance
with antiviral activity. Work within the last several decades
has deﬁned two classes of antiviral substances: type I IFNs
(IFNa/b), which signal via a shared receptor, and type II IFN
(IFNc), which signals via a unique IFNc receptor. Interest-
ingly, in the 1960s, CHIKV was used to stimulate IFN
production from chick embryo ﬁbroblast–like cells [20,21],
but the effect of IFNs on CHIKV infection has not been
assessed. We determined the potential role of IFNs in limiting
CHIKV infection by using the HeLa infection system. Cells
were pretreated with either IFNa1b, IFNb1a, or IFNc for 6 h, at
a dose ranging from 10 to 1,000 IU/ml, and viral replication
was then analyzed by ﬂow cytometry. Interestingly, the three
IFNs potently inhibited the expression of viral proteins
(Figure 7A). Moreover, treatment with IFN strongly decreased
virus-induced CPE (Figure 7B). Similar results were obtained
with the four viral strains, indicating that CHIKV is highly
sensitive to the antiviral effect of IFNs. Of note, CHIKV
replication was also strongly inhibited by IFN in macrophages
(not shown), indicating that the antiviral effect of IFN is also
visible in primary cells.
Discussion
We describe here the replication features of CHIKV, a virus
responsible for recent epidemic outbreaks in India and other
countries in the Indian Ocean region. So far, this virus species
has not been scrutinized using modern-day techniques. We
have designed a panel of assays in order to follow viral
replication and to describe the cellular tropism of CHIKV in
culture experiments. We report that CHIKV replicates in
various human adherent cells, including epithelial and
endothelial cells, and primary ﬁbroblasts and macrophages.
In contrast, T and B lymphocytes and monocyte-derived DCs
are not susceptible. Viral entry occurs through a pH-
dependent, endocytic pathway. The life cycle of this virus is
Figure 7. CHIKV Entry Pathway
(A and B) CHIKV infection requires a low endosomal pH for entry. HeLa cells were pretreated 1 h before infection with chloroquine (10 lM) or
bafilomycin-A1 (25 nM) and exposed to CHIKV (moi 10), or treated with the two drugs 3 h after viral exposure.
(A) Inhibition of CHIKV replication by chloroquine and bafilomycin-A1. At 24 h pi, HeLa cells were stained with mouse anti-CHIKV antibodies and
analyzed by flow cytometry. Ctrl, control.
(B) Inhibition of CHIKV CPE by chloroquine and bafilomycin-A1. Cell viability was measured in a colorimetric assay (MTT cell viability test) 24 h pi.
(C) Downregulation of Dyn-2 expression by shRNAs. HeLa cells were transduced with a lentiviral vector expressing GFP and a shRNA against Dyn-2 or an
unrelated protein as a control (Ctrl). Upper panel: The Western blot shows the downregulation of Dyn-2 expression. Lower panel: surface levels of
transferrin receptor (Tf-R) were upregulated in the absence of Dyn-2. Flow cytometry analysis was gated on transduced GFPþ cells.
(D) Dyn-2 is required for CHIKV replication. HeLa cells lacking Dyn-2 are resistant to CHIKV. Infected HeLa cells (moi 10, 24 h pi) were stained with anti-
CHIKV antibodies and analyzed by flow cytometry. The percentage of CHIKVþ cells among GFPþ and GFP cells is depicted. One representative
experiment out of three is shown in the upper panel. A mean 6SD of four independent experiments is shown in the lower panel.
NI, noninfected cells.
doi:10.1371/journal.ppat.0030089.g007
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short: as soon as 8–16 h pi, numerous newly infected cells can
be detected, which release high levels of progeny virions.
Viral titers in supernatants reach 105–108 TCID50/ml,
depending on the cell type. CHIKV is highly cytopathic for
mammalian cells, inducing apoptosis of infected cells. More-
over, CHIKV replication is signiﬁcantly inhibited by type I
and II IFNs. These characteristics generally correspond to
those of other alphaviruses, among which the most studied
are SINV, SFV, and RRV [14,31,39,40]. The alphavirus genus
contains over 20 members, which likely diverged 2,000 to
3,000 years ago [40]. Some alphaviruses are nonpathogenic in
humans, whereas others cause different diseases with various
intensities, and can be broadly divided into the American
encephalitis viruses and the globally distributed arthritogenic
viruses [2,41]. Each virus type has thus likely evolved its own
way of interacting with the host.
So far, alphaviruses have been mostly studied in murine
and other animal cells. In particular, the interaction of
CHIKV with human cells has not been characterized. We have
reported here that some human epithelial and endothelial
cells and ﬁbroblasts are sensitive to CHIKV. Together with
the recent ﬁnding that CHIKV replicates in human muscle
satellite cells, and not in differentiated myotubes [42], our
results indicate that CHIKV displays a rather wide tropism
for adherent cells. However, CHIKV neither efﬁciently
replicated in hCMEC/D3 endothelial cells nor in A549
epithelial cells. The identiﬁcation of such CHIKV-resistant
cells will be useful for further studies aimed at deciphering
entry or post-entry viral events. For instance, the cellular
receptors for CHIKV are not known. We generally observed a
direct correlation between viral binding and infection of
target cells (Table 1). Our results suggest that hCMEC/D3 cells
are not infected, because of the absence of surface binding
receptors. The situation may be different with A549 cells,
which are refractory to infection but still able to bind viral
particles. A549 cells may either nonspeciﬁcally bind incoming
virions (through receptors not involved in productive entry),
or restrict infection at a post-binding step.
As for other alphaviruses [14,16,43], CHIKV entry is pH-
dependent. Viral replication is blocked by compounds
inhibiting endosomal acidiﬁcation and likely requires the
clathrin machinery, as demonstrated by the requirement of
Dyn-2 for viral replication. Dyn-2 also controls clathrin-
independent uptake via caveolae [38,44], and it will be thus of
interest to examine whether caveolae are also involved in
CHIKV entry. Although chloroquine blocked CHIKV repli-
cation, the therapeutic (antiviral) index of chloroquine in cell
cultures is rather narrow (Figure 7); thus, one should be
cautious when proposing the use of chloroquine as an
antiviral treatment in infected individuals.
CHIKV is highly cytopathic in human cell cultures, and
infected cells rapidly undergo apoptosis. Alphavirus repli-
Figure 8. IFNs Inhibit CHIKV Infection
HeLa cells were pretreated 6 h before infection with the indicated doses (IU/mL) of IFN. IFNa1b , IFNb1a, and IFNc were tested. Cells were then exposed
to CHIKV at two mois (10 and 1).
(A) Inhibition of CHIKV replication. At 24 h pi, HeLa cells were stained with anti-CHIKV antibodies and analyzed by flow cytometry.
(B) Inhibition of CHIKV CPE. Cell viability was measured in a colorimetric assay (MTT cell viability test) 24 h pi (moi of 10). Data are representative of three
independent experiments.
doi:10.1371/journal.ppat.0030089.g008
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cation strongly affects fundamental cell physiology processes,
with an inhibition of cellular transcription and translation,
and a redirection of cellular resources towards the synthesis
of viral proteins and genomes [45]. Induction of apoptosis by
SINV occurs at the level of cell entry, without requiring virus
replication [46,47]. Determining whether this is also the case
for CHIKV, and whether apoptosis of CHIKV-infected cells is
involved in pathogenesis, will require further investigations.
IFNs are essential components of the innate immune
system, protecting against alphaviral disease [14,48,49]. A
2005 study proposed a correlation between alphavirus
virulence and resistance to type I IFNs, as reported for the
Eastern equine encephalitis virus [49]. We show here that the
situation may be different for CHIKV, since this pathogenic
virus retains full sensitivity to type I and II IFNs in cell
cultures. This strongly suggests that the innate immune
system controls the virus and is responsible for the rapid
decline (a few days) of viremia observed during the acute
phase of infection. It will be useful to determine which IFN-
induced proteins mediate the inhibition of CHIKV replica-
tion. An interesting candidate is ISG15, which was recently
shown to function as a critical antiviral molecule against
SINV in mouse [50].
In contrast to adherent cells, primary lymphocytes, T cell, B
cell, and monocytoid lines did not allow CHIKV replication.
Similar results have been described for RRV and SFV [51,52].
Retroviral vectors pseudotyped with envelope glycoproteins
from these two alphaviruses efﬁciently transduced adherent
cells, but failed to infect lymphocytes and monocytes [51,52].
This is probably due to the lack of adequate receptor
expression in lymphocytes and monocytes. One can speculate
that CHIKV receptors are also absent in these cells, as
supported by the lack of virus binding in our assay. Since a
high peak of viremia occurs during the acute phase of
chikungunya disease (P. Laurent, K. Le Roux, P. Grivard, G.
Bertil, F. Naze, et al., unpublished data), we sought to
determine whether PBMCs from acutely infected individuals
harbor CHIKV. We did not observe detectable levels of viral
RNA in the blood cell fraction from three individuals with a
plasmatic viral load ranging from 105– 108 RNA copies/ml
(not shown). Therefore, PBMCs are not sensitive to CHIKV in
vitro, and are probably not infected in vivo.
Human monocyte–derived DCs were not sensitive to
CHIKV replication. Multiple parameters regulate the ability
of alphaviruses to infect DCs; for instance, RRV envelope
glycoproteins allow infection of murine, and not human DCs
[52]. Infection of human DCs by a SINV vector is determined
by a single amino acid substitution in E2 [53]. In a mouse
model, the in vivo targeting of Venezuelan equine encepha-
litis virus to skin DCs is required for pathogenesis, and is also
regulated by amino acids in E2 [54]. On the other hand,
mosquito cell–derived RRV and Venezuelan equine encepha-
litis virus exhibit enhanced infection of murine myeloid DCs,
compared to mammalian cell–derived preparations [55]. This
is due to a better induction of type I IFN by viruses produced
in mammalian cells [55]. In our hands, monocyte-derived DCs
were insensitive to CHIKV produced in either mosquito (C6/
36) or human (HeLa) cells. Similar results were observed with
immature and mature DCs, and exposure of immature DCs to
CHIKV (from C6/36 or HeLa cells) did not induce their
maturation, nor promote type I IFN production (not shown).
Our results strongly suggest that monocyte-derived DCs are
intrinsically resistant to CHIKV. Further work should
examine the sensitivity of other DC subsets, like plasmacytoid
DCs and Langerhans cells.
We demonstrate here that in contrast to DCs, human
primary macrophages are susceptible to CHIKV. Infection of
macrophages is associated with release of infectious viral
progeny in the supernatants. This process is less efﬁcient than
in HeLa cells, with only 5%–50% of the cell population being
positive, and viral titers plateauing at 104–105 pfu/ml,
depending on cell donors. This restricted replication may
be due to the secretion of IFN or other cytokines by infected
macrophages. RRV, another arthritogenic virus, also infects
macrophages [41,56–58]. Macrophages have been implicated
in the pathogenesis of RRV disease, at least in a mouse model
of infection. In this model, inﬁltrates of inﬂammatory
macrophages are observed in muscles and joints [41,59], and
treatment of mice with macrophage-toxic agents abrogated
symptoms [60]. Moreover, RRV can induce persistent
productive infection of macrophages in cultures [56,61].
Antibody-dependent enhancement of RRV infection in
monocyte/macrophage cell lines has been reported, but
whether this process plays a role in vivo remains to be
proven [41,56].
There are, however, noticeable differences between RRV
and CHIKV interactions with macrophages. First, RRV has
been mostly studied using murine monocytic/macrophage
cells, or human monocytoid cells, and to our knowledge,
there is no evidence for RRV infecting primary human
macrophages. Moreover, RRV [56], and not CHIKV (Figure
4B), infects monocytoid cells such as U937 cells. CHIKV
induces a sudden onset of severe arthritis and fever, whereas
RRV-induced symptoms are generally mild and more gradual
[40]. Whether these differences are linked to a differential
interaction of the viruses with macrophages in vivo remains
to be determined.
During the recent outbreak of CHIKV in La Re´union, an
evolution of the viral genome was reported when comparing
initial and later circulating strains. In particular, the selection
of a mutant of the E1 glycoprotein (A226V) was noted [5]. In
our studies, we have used four clinical CHIKV strains with
different sequences. All the variants behave similarly in our
assays, suggesting that the reported evolution is not due to the
selection of viruses with a modiﬁed tropism for human cells.
Overall, our results provide fresh insights into the
replication of alphaviruses and the pathogenesis of CHIKV.
We identiﬁed a panel of human cell types sensitive to CHIKV,
and our next aim is to further characterize how CHIKV
interacts with these cells. It will be of interest to determine
how DCs, macrophages, and other cell types sense CHIKV,
and which cytokines are produced during the encounter. It
will be also useful to correlate our results with the situation in
vivo, for example, by determining in biological samples from
CHIK-infected individuals which cells harbor the virus during
both acute and chronic phases of the disease.
Materials and Methods
Cells and reagents. HeLa cells, 293T cells, primary skin cells (Hs
789.Sk, American Type Culture Collection [ATCC] number 7518;
http://www.atcc.org), TrHBMEC, BEAS-2B cells, MRC5 cells, and Vero
cells were grown in DMEM medium with 10% heat-inactivated fetal
bovine serum (FBS). hCMEC/D3 were grown in EBM2 medium
(Clonetics, http://www.cambrex.com) with 5% heat-inactivated FBS.
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A549 cells were grown in F12K medium with 10% heat-inactivated
FBS. TrHBMEC and hCMEC/D3 cells, a kind gift of Babette Weksler,
Ignacio Romero, and Pierre-Olivier Couraud, are permanent human
endothelial cell lines isolated from the bone marrow and the brain,
respectively [32,33]. MRC5 cells are primary human fetal lung
epithelial cells (ATCC number CCL-171). A549 (ATCC number
CCL-185) are human malignant alveolar type II pneumocytes and
BEAS-2B (ATCC number CRL-9609) cells are SV40-transformed
human airway epithelial cells. Resting MRC5 cells were obtained by
maintaining conﬂuent cultures in serum-free medium with 106 M
dexametasone for at least 10 d before viral exposure (95% of the cells
at G0/G1 by ﬂow cytometry analysis of the cell cycle, not shown).
Buffy-coat PBMCs from healthy donors were isolated by Ficoll
centrifugation. CD4þ T lymphocytes were isolated by negative
selection using magnetic beads (Miltenyi Biotec, http://www.
miltenyibiotec.com). B-420 cells are EBV-immortalized B cells [62].
THP-1 and U937 monocytoid cells, Jurkat T cells, PBMCs, and
primary lymphocytes and monocytes were grown in RPMI medium
with 10% FBS. A. albopictus C6/36 cells were grown at 28 8C in
Leibovitz-L15 medium supplemented with 5% FBS and tryptose-
phosphate. DCs were prepared as described [62,63]. CD14þ mono-
cytes were isolated from PBMCs by positive selection using magnetic
beads (Miltenyi Biotec). To allow differentiation of macrophages,
monocytes were cultured for 7 d before use in RPMI 1640 medium
with 5% human AB-positive serum and 5% SVF and rHu M-CSF (12.5
ng/mL) (Promokine, http://www.promokine.de). Chloroquine and
baﬁlomycin were from Sigma (http://www.sigmaaldrich.com), IFNs
from ImmunoTools (http://www.immunotools.de).
Antibodies. The following antibodies were used: a mAb directed
against a conserved region of the alphavirus nucleocapsid protein
(anti-C), a kind gift of Isabelle Greiser-Wilke [28]; mouse polyclonal
anti-CHIKV antibodies [5]; anti-Dyn-2 mAb (Afﬁnity BioReagents,
http://www.bioreagents.com); anti-actin mAb (Sigma); and anti-active
caspase-3 mAb (Caspase 3 Apoptosis Kit; BD Pharmingen, http://www.
bdbiosciences.com).
CHIKV titration. Viral samples were titrated as TCID50/mL on
Vero cells using a standard procedure. Brieﬂy, serial dilutions (100
lL) of cell culture supernatants were added in 8-plicates into 96-well
plates seeded with 104 Vero cells. The CPE was scored 5 d after
infection and the titer was calculated by determining the last dilution
giving 50% of wells with cells displaying a CPE. Similar titers were
obtained using a focus immunoassay [5].
CHIKV infection. The preparation of CHIKV from clinical samples
has been described [5]. The four CHIKV strains were propagated
twice in C6/36 cells, and supernatants were harvested and frozen at
80 8C as described [5] before titration and further use. Adherent
cells (plated at about 25% conﬂuence in 6- or 24-well plates), and
nonadherent cells (0.5 3 106–1 3 106 cells/experimental point) were
exposed to the indicated viruses for 2–4 h at 37 8C, extensively
washed, and cultivated for various periods of time before further
analysis. The moi was deﬁned as the amount of CHIKV infectious
units (calculated on Vero cells as a TCID50) per one target cell.
CHIKV binding. Adherent cells (plated at about 5 3 105 cells/
experimental point in 6-well plates) and nonadherent cells (5 3 105
cells/experimental point) were exposed (1 h at 4 8C) to CHIKV
(CHIKV-21 or CHIKV-115 strains) at the indicated moi in a ﬁnal
volume of 1 ml and extensively washed. Expression of CHIKV
proteins was then analyzed by ﬂow cytometry after staining with
mouse polyclonal anti-CHIKV antibodies.
Flow cytometry, confocal microscopy, and Western blot analysis.
Expression of CHIKV proteins was analyzed on permeabilized cells
with the anti-alphavirus C mAb [28] or with the polyclonal anti-
CHIKV serum [5]. Samples were analyzed by ﬂow cytometry using a
FACSCalibur (Becton Dickinson, http://www.bdbiosciences.com), with
FlowJo software (http://www.ﬂowjo.com). For immunoﬂuorescence,
cells were analyzed by confocal microscopy on a Zeiss LSM510
instrument (http://www.zeiss.com). For Western blot, cells were lyzed
in lysis buffer (1% Triton X-100–PBS) with Complete Protease
Inhibitor Cocktail tablets (Roche, http://www.roche.com). Cell super-
natants (1 ml) were pelleted by ultracentrifugation (45 min at 50,000
rpm) in a TL-100 rotor (Beckman, http://www.beckman.com), and
resuspended in 100 ll of lysis buffer. An equivalent of 10 lg of total
cell lysate or 15 ll of ultracentrifugated supernatant was loaded on
each well of a 4%–12 % gradient polyacrylamide gel. Western
blotting was performed with a mix of anti-C and anti-CHIKV
antibodies.
Cell viability. Cell viability was measured using a classical MTT
assay [64]. HeLa cells were plated in 96-well plates and exposed to the
indicated virus. After 24 to 48 h, 70 lg of MTT (3-(4,5-dimethyl-2-
thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide, Sigma) (10 lL of 7
mg/mL solution) was added to 100 lL of culture medium for a 5-h
incubation in a CO2 incubator at 37 8C. The medium was then
removed and crystals were solubilized using 100 lL acid isopropanol
(0.04 N HCl in isopropanol). Plates were read on an ELISA reader
using a test wavelength of 550 nm.
Quantiﬁcation of CHIKV RNA by real-time PCR. Cells were
exposed to the indicatedmoi ofCHIKV for 2–4h,washedwithPBS, and
cultured for the indicated periods of time. RNA was prepared from
supernatants using the MagNA pure LC total nucleic acid isolation kit
(Roche Diagnostics, http://www.roche.com). CHIKV RNA levels were
measured with a Light Cycler (Roche Diagnostics) (P. Laurent, K. Le
Roux, P. Grivard, G. Bertil, F. Naze, et al., unpublished data).
Electron microscopy. HeLa cells were infected with CHIKV (moi 1).
At 36 h after infection, cells were ﬁxed in PBS-3% glutaraldehyde for
1 h and post-ﬁxed in PBS-1% osmium tetroxide for 2 h. After rinsing
in PBS, cells were transferred to 0.2 M cacodylate buffer for 30 min.
Cells were washed in 30% methanol for 10 min, stained in 2% uranyl
acetate–30% methanol for 1 h, and washed in 30% methanol. Cells
were then dehydrated in an ethanol series to propylene oxyde and
embedded in Epon 812. Cells were examined with a JEOL 1200EX2
microscope (http://www.jeol.com).
Lentiviral vectors expressing shRNAs. Lentiviral vectors express-
ing GFP and shRNA (against Dyn-2 or an irrelevant protein as a
control) were produced and used as described [39].
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